Lyell Immunopharma earnings were -$334.5M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest LYEL earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$52.2M, down 72.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LYEL reported annual earnings of -$343.0M, with 46.2% growth. The next LYEL earnings date is Aug 6, 2025.
What were Lyell Immunopharma's earnings last quarter?
Lyell Immunopharma (NASDAQ: LYEL) reported Q1 2025 earnings per share (EPS) of -$3.60, up 25% year over year. Total LYEL earnings for the quarter were -$52.20 million. In the same quarter last year, Lyell Immunopharma's earnings per share (EPS) was -$4.80.
The next LYEL earnings date is Invalid Date. Add LYEL to your watchlist to be reminded of Lyell Immunopharma's next earnings date.
Is Lyell Immunopharma profitable or losing money?
As of the last Lyell Immunopharma earnings report, Lyell Immunopharma is currently losing money. Lyell Immunopharma's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$334.52 million, a 46.5% increase year over year.
What was LYEL's earnings growth in the past year?
As of Lyell Immunopharma's earnings date in Q3 2025, Lyell Immunopharma's earnings has grown year over year. LYEL earnings in the past year totalled -$334.52 million.
What are Lyell Immunopharma's earnings expectations?
The current EPS estimate for Lyell Immunopharma's earnings report in Invalid Date is -$0.16.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.